Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-08-04 20:31 Tx date 2021-07-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+14,309 vol |
577,739 | |
Filed 2021-05-07 16:59 Tx date 2021-05-03 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$103,499
+75,000 vol $1.38 each |
405,000 | |
Filed 2021-05-06 10:10 Tx date 2021-05-06 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-14,400
-30,000 vol $0.48 each |
300,000 | |
Filed 2021-05-05 22:20 Tx date 2021-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+13,974 vol |
563,430 | |
Filed 2021-03-02 21:41 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
34,000 | |
Filed 2021-03-02 21:35 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
0 | |
Filed 2021-03-02 21:30 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
Filed 2021-03-02 21:29 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
-10,000 | |
Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
1,250,000 | |
Filed 2021-02-03 20:34 Tx date 2021-01-29 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+11,718 vol |
549,456 | |
Filed 2020-11-04 18:29 Tx date 2020-10-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+13,823 vol |
537,738 | |
Filed 2020-08-06 07:33 Tx date 2020-07-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+15,287 vol |
523,915 | |
Filed 2020-06-08 12:14 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,200
+10,000 vol $0.22 each |
10,000 | |
Filed 2020-06-08 12:04 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-06-08 11:51 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$47,800
+20,000 vol $2.39 each |
24,000 | |
Filed 2020-05-05 20:42 Tx date 2020-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$78,750
+75,000 vol $1.05 each |
330,000 | |
Filed 2020-05-05 20:38 Tx date 2020-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+17,383 vol |
508,628 | |
Filed 2020-05-01 19:24 Tx date 2020-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-840,000
-30,000 vol $28.00 each |
255,000 | |
Filed 2020-02-05 21:21 Tx date 2020-01-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+21,247 vol |
491,245 | |
Filed 2019-11-21 21:37 Tx date 2019-11-19 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$76,000
+50,000 vol $1.52 each |
130,000 | |
Filed 2019-11-20 17:03 Tx date 2019-11-19 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
46 - Compensation for services
|
+10,867 vol |
64,459 | |
Filed 2019-11-14 09:15 Tx date 2019-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+18,892 vol |
469,998 | |
Filed 2019-11-04 17:06 Tx date 2019-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+19,892 vol |
||
Filed 2019-11-04 17:06 Tx date 2019-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+19,892 vol |
470,998 | |
Filed 2019-10-15 14:55 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Control or Direction)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,840
+4,000 vol $2.71 each |
4,000 | |
Filed 2019-10-15 14:53 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-09-18 20:34 Tx date 2019-09-18 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU's)
56 - Grant of rights
|
+126,000 vol |
200,500 | |
Filed 2019-08-06 07:10 Tx date 2019-07-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+16,837 vol |
451,106 | |
Filed 2019-06-19 15:06 Tx date 2019-06-18 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,750
+15,000 vol $0.65 each |
45,000 | |
Filed 2019-06-19 15:03 Tx date 2019-06-18 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,750
-15,000 vol $0.65 each |
80,000 | |
Filed 2019-05-18 17:47 Tx date 2019-05-15 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,750
+35,000 vol $0.45 each |
225,000 | |
Filed 2019-05-18 17:43 Tx date 2019-05-15 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,750
-35,000 vol $0.45 each |
285,000 | |
Filed 2019-05-04 19:33 Tx date 2019-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$72,750
+75,000 vol $0.97 each |
320,000 | |
Filed 2019-05-04 19:30 Tx date 2019-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+14,067 vol |
434,269 | |
Filed 2019-02-25 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
0 | |
Filed 2019-02-25 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
||
Filed 2019-02-21 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
0 | |
Filed 2019-02-05 Tx date 2019-01-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+11,713 vol |
420,202 | |
Filed 2019-02-05 Tx date 2019-01-31 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
46 - Compensation for services
|
+1,875 vol |
53,592 | |
Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+40,000 vol |
40,000 | |
Filed 2018-12-27 Tx date 2018-08-28 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
37 - Stock split or consolidation
|
+600,000 vol |
1,200,000 | |
Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
11 - Acquisition or disposition carried out privately
|
$6,000
+600,000 vol $0.01 each |
600,000 | |
Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$200,000
+40,000 vol $5.00 each |
1,240,000 | |
Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-26 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-11-05 Tx date 2018-10-31 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
46 - Compensation for services
|
+1,972 vol |
51,717 | |
Filed 2018-11-05 Tx date 2018-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+18,174 vol |
408,489 | |
Filed 2018-09-29 Tx date 2010-12-06 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-09-29 Tx date 2010-12-06 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU's)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-09-29 Tx date 2018-09-24 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU's)
46 - Compensation for services
|
+28,100 vol |
74,500 | |
Filed 2018-09-29 Tx date 2018-09-24 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
46 - Compensation for services
|
+49,745 vol |
49,745 | |
Filed 2018-09-29 Tx date 2018-09-24 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (RSU's)
46 - Compensation for services
|
+46,400 vol |
46,400 | |
Filed 2018-08-03 Tx date 2018-07-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+20,961 vol |
390,315 | |
Filed 2018-07-23 Tx date 2018-07-09 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-41,100
-30,000 vol $1.37 each |
||
Filed 2018-07-23 Tx date 2010-12-06 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-07-23 Tx date 2018-07-06 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$41,100
+30,000 vol $1.37 each |
30,000 | |
Filed 2018-07-23 Tx date 2018-07-06 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-41,100
-30,000 vol $1.37 each |
125,000 | |
Filed 2018-07-23 Tx date 2018-07-09 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-41,100
-30,000 vol $1.37 each |
||
Filed 2018-07-16 Tx date 2018-07-09 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-95,700
-30,000 vol $3.19 each |
95,000 | |
Filed 2018-07-16 Tx date 2018-07-09 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-41,100
-30,000 vol $1.37 each |
125,000 | |
Filed 2018-05-04 Tx date 2018-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$48,750
+75,000 vol $0.65 each |
275,000 | |
Filed 2018-05-04 Tx date 2018-05-02 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,600
-30,000 vol $0.32 each |
245,000 | |
Filed 2018-05-04 Tx date 2018-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+21,177 vol |
369,354 | |
Filed 2018-05-04 Tx date 2018-05-02 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,600
+30,000 vol $0.32 each |
190,000 | |
Filed 2018-02-02 Tx date 2018-01-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+21,328 vol |
348,177 | |
Filed 2017-12-04 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$46,000
+40,000 vol $1.15 each |
235,000 | |
Filed 2017-12-04 Tx date 2017-12-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,660 vol |
||
Filed 2017-12-04 Tx date 2017-12-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,660 vol |
102,790 | |
Filed 2017-11-01 Tx date 2017-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+27,338 vol |
326,849 | |
Filed 2017-10-04 Tx date 2017-10-02 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+22,185 vol |
299,511 | |
Filed 2017-09-07 Tx date 2017-09-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,181 vol |
94,130 | |
Filed 2017-06-06 Tx date 2017-06-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+3,723 vol |
85,949 | |
Filed 2017-05-02 Tx date 2017-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,200
-30,000 vol $0.14 each |
125,000 | |
Filed 2017-05-02 Tx date 2017-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,250
+75,000 vol $0.59 each |
200,000 | |
Filed 2017-05-02 Tx date 2017-04-28 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+21,149 vol |
277,326 | |
Filed 2017-05-02 Tx date 2017-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,200
+30,000 vol $0.14 each |
160,000 | |
Filed 2017-03-13 Tx date 2017-03-13 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
$10,760
+3,128 vol $3.44 each |
82,226 | |
Filed 2017-02-03 Tx date 2017-01-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+18,463 vol |
256,177 | |
Filed 2016-12-02 Tx date 2016-12-02 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+2,356 vol |
79,098 | |
Filed 2016-11-03 Tx date 2016-10-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+22,884 vol |
237,714 | |
Filed 2016-09-03 Tx date 2016-09-02 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+4,083 vol |
76,742 | |
Filed 2016-09-01 Tx date 2016-08-31 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$84,700
+35,000 vol $2.42 each |
195,000 | |
Filed 2016-08-03 Tx date 2016-07-29 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+23,007 vol |
214,830 | |
Filed 2016-06-19 Tx date 2016-06-14 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
155,000 | |
Filed 2016-06-19 Tx date 2016-06-14 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-30,000 vol |
155,000 | |
Filed 2016-06-19 Tx date 2016-06-14 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,500
+30,000 vol $0.15 each |
130,000 | |
Filed 2016-06-07 Tx date 2016-06-07 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+5,121 vol |
72,659 | |
Filed 2016-05-03 Tx date 2016-04-29 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+23,926 vol |
191,823 | |
Filed 2016-05-03 Tx date 2016-05-02 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$14,400
+30,000 vol $0.48 each |
185,000 | |
Filed 2016-05-03 Tx date 2016-05-02 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$69,500
+50,000 vol $1.39 each |
185,000 | |
Filed 2016-04-01 Tx date 2016-04-01 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Defferred Share Unit
46 - Compensation for services
|
+109,433 vol |
253,539 | |
Filed 2016-03-04 Tx date 2016-03-04 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+3,265 vol |
67,538 | |
Filed 2016-02-02 Tx date 2016-01-29 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+19,667 vol |
167,897 | |
Filed 2016-01-07 Tx date 2015-12-01 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
$10,765
+4,272 vol $2.52 each |
64,273 | |
Filed 2016-01-07 Tx date 2016-01-06 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$40,500
+150,000 vol $0.27 each |
325,000 | |
Filed 2016-01-04 Tx date 2016-01-04 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,783
+7,418 vol $0.51 each |
389,454 | |
Filed 2015-12-28 Tx date 2015-12-24 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-156,750
-75,000 vol $2.09 each |
135,000 | |
Filed 2015-12-16 Tx date 2015-12-16 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-75,000 vol |
155,000 | |
Filed 2015-12-16 Tx date 2015-12-16 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,750
+75,000 vol $0.21 each |
100,000 | |
Filed 2015-12-03 Tx date 2015-11-30 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$50,400
+20,000 vol $2.52 each |
160,000 | |
Filed 2015-11-19 Tx date 2015-11-16 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
38 - Redemption, retraction, cancellation, repurchase
|
-$8 vol |
$42 | |
Filed 2015-11-03 Tx date 2015-10-30 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+41,868 vol |
148,230 | |
Filed 2015-10-20 Tx date 2015-10-20 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Defferred Share Unit
46 - Compensation for services
|
$11,598
+29,816 vol $0.389 each |
144,106 | |
Filed 2015-10-20 Tx date 2015-10-20 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Defferred Share Unit
46 - Compensation for services
|
$11,524
+29,625 vol $0.389 each |
||
Filed 2015-09-02 Tx date 2015-09-01 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+3,695 vol |
60,001 | |
Filed 2015-08-05 Tx date 2015-07-31 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Defferred Share Unit
46 - Compensation for services
|
+28,105 vol |
114,290 | |
Filed 2015-08-05 Tx date 2015-07-31 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+28,278 vol |
106,362 | |
Filed 2015-07-23 Tx date 2015-07-23 |
$AHF
Aston Hill Financial Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R. Smith & Associates (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,600
+20,000 vol $0.53 each |
634,300 | |
Filed 2015-07-07 Tx date 2015-07-07 |
$CNQ
Canadian Natural Resources Limited |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
$11,158
+334 vol $33.41 each |
18,334 | |
Filed 2015-06-05 Tx date 2015-06-04 |
$I
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
$11,743
+2,914 vol $4.03 each |
56,306 | |
Filed 2015-05-05 Tx date 2015-05-01 |
$RVX
Resverlogix Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$84,600
+30,000 vol $2.82 each |
210,000 | |
Filed 2015-05-05 Tx date 2015-05-01 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$8,400
+30,000 vol $0.28 each |
230,000 | |
Filed 2015-04-30 Tx date 2015-04-30 |
$
Zenith Epigenetics Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+44,403 vol |
78,084 |